Single Nucleotide Polymorphisms genotyping is a method of examining and viewing genetic variations of SNPs between the elements of the species. It is a forthcoming field of interest for researchers for study of life sciences discipline and genomics. Single Nucleotide Polymorphisms genotyping has many uses in different business sectors like biotechnological farming, pharmaceuticals and research studies. This results in high yield of dairy items, meat and crops. The application of SNP genotyping is increasing fast from animal technology and genetic testing to plant technology. Single Nucleotide Polymorphism genotyping provides an overview of the human genome features as well as transmission of hereditary diseases. SNP genotyping is of great value for the medical fields and the pharmaceutical as it forecasts disease involvement and the response of a person for specific prescription. Human SNP genotyping has many suggestions in diseases treatment and prediction, new innovative discovery of drugs, clinical diagnostics and improved medical practice.
Few of the driving aspects for SNP genotyping market are raising occurrence of fatal diseases like diabetes and cancer, increased demand for genetic analysis in plant as well as animal feedstock and presence of public funding and private funding programs in area of genetics. Depending upon the product, SNP genotyping market is bifurcated into reagent or consumables, services and equipments. Beginning of technological modernizations on the accuracy levels as well as portability and cost effectiveness like increased use of real time and multiplex polymer chain reaction and massarrays system is predicted to encourage the SNP genotyping market at a fast pace. Depending upon the application, the market is bifurcated into pharmaceuticals, diagnostic research, pharmacogenomics, animal livestock, farming biotechnology and breeding. Depending upon the technology, the SNP genotyping market is bifurcated into microarrays, sequenom massarrays, taqman allelic discrimination, SNP gene chips, SNP pyrosequencing and applied biosciences SNPlex.
Universally, SNP genotyping market is bifurcated into four key areas: North America, Rest of the World, Europe and Asia Pacific. North American region is considered as the market leader due to favorable government regulations towards screening & treatment of fatal ailments, proper medical diagnosis and accessibility of good R & D facilities and presence of modern techniques. Asia Pacific market as well as European market is evolving due to growth, expansion and development of different strategies and government regulations. Increasing occurrences of targeted ailments, improvement in healthcare activities, rising demand for custom-made medicines and rapid economic growth adds to SNP genotyping market growth in regions of Asia Pacific and Europe.
Key industry players of the SNP genotyping market include Douglas Scientific LLC, Sequenom Incorporation, Biosoft, Life Technologies Corporation, Illumina Incorporation, Fluidigm and Affymetrix Incorporation.
